These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 16077988)
1. Release of bFGF following apoptosis and necrosis in NSCLC cells: effects on chemosensitivity to cisplatin. Kuhn H; Weser L; Gessner C; Hammerschmidt S; Wirtz H Oncol Rep; 2005 Sep; 14(3):759-62. PubMed ID: 16077988 [TBL] [Abstract][Full Text] [Related]
2. Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell lines. Kuhn H; Köpff C; Konrad J; Riedel A; Gessner C; Wirtz H Lung Cancer; 2004 May; 44(2):167-74. PubMed ID: 15084381 [TBL] [Abstract][Full Text] [Related]
3. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Brenes O; Arce F; Gätjens-Boniche O; Díaz C Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342 [TBL] [Abstract][Full Text] [Related]
5. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094 [TBL] [Abstract][Full Text] [Related]
6. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer. Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770 [TBL] [Abstract][Full Text] [Related]
7. Polysaccharide of Cordyceps sinensis enhances cisplatin cytotoxicity in non-small cell lung cancer H157 cell line. Ji NF; Yao LS; Li Y; He W; Yi KS; Huang M Integr Cancer Ther; 2011 Dec; 10(4):359-67. PubMed ID: 21382957 [TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of VEGF following bFGF inhibition in non-small cell lung cancer cell lines. Kuhn H; Konrad J; Holtz S; Salameh A; Gessner C; Hammerschmidt S; Wirtz H Lung Cancer; 2006 Nov; 54(2):149-53. PubMed ID: 16934908 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells. Zhang LJ; Hao YZ; Hu CS; Ye Y; Xie QP; Thorne RF; Hersey P; Zhang XD Anticancer Drugs; 2008 Feb; 19(2):159-66. PubMed ID: 18176112 [TBL] [Abstract][Full Text] [Related]
10. Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells. Woods DC; Alvarez C; Johnson AL Gynecol Oncol; 2008 Mar; 108(3):632-40. PubMed ID: 18191995 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor and basic fibroblast growth factor are released by squamous cell carcinoma cells after irradiation and increase resistance to subsequent irradiation. Brieger J; Schroeder P; Gosepath J; Mann WJ Int J Mol Med; 2005 Jul; 16(1):159-64. PubMed ID: 15942693 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effects of camptothecin and cisplatin combined with tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) in a model of primary culture of non-small cell lung cancer. Frese S; Schüller A; Frese-Schaper M; Gugger M; Schmid RA Anticancer Res; 2009 Aug; 29(8):2905-11. PubMed ID: 19661294 [TBL] [Abstract][Full Text] [Related]
13. [Role of Smac in cisplatin-induced apoptosis of non-small cell lung cancer cells]. Cheng XD; Cai SX; Zhao HJ; Li WJ; Tong WC Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):389-91. PubMed ID: 18359697 [TBL] [Abstract][Full Text] [Related]
14. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells. Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158 [TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor sensitizes NIH 3T3 cells to apoptosis induced by cisplatin. Coleman AB; Momand J; Kane SE Mol Pharmacol; 2000 Feb; 57(2):324-33. PubMed ID: 10648642 [TBL] [Abstract][Full Text] [Related]
16. Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines. Koshimune R; Aoe M; Toyooka S; Hara F; Ouchida M; Tokumo M; Sano Y; Date H; Shimizu N BMC Cancer; 2007 Jan; 7():8. PubMed ID: 17222343 [TBL] [Abstract][Full Text] [Related]
17. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429 [TBL] [Abstract][Full Text] [Related]
18. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation. Checinska A; Hoogeland BS; Rodriguez JA; Giaccone G; Kruyt FA Exp Cell Res; 2007 Apr; 313(6):1215-24. PubMed ID: 17291493 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner. Wu XX; Kakehi Y Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256 [TBL] [Abstract][Full Text] [Related]
20. Curcumin sensitizes lung cancer cells to cisplatin-induced apoptosis through superoxide anion-mediated Bcl-2 degradation. Chanvorachote P; Pongrakhananon V; Wannachaiyasit S; Luanpitpong S; Rojanasakul Y; Nimmannit U Cancer Invest; 2009 Jul; 27(6):624-35. PubMed ID: 19283527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]